Drugs

Cleveland BioLabs Announces Board Appointment

BUFFALO, NY: ...

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Liposomal Encapsulated Paclitaxel for the Treatment of Ovarian Cancer

PHOENIX, AZ: ...

Knight Therapeutics Inc. Announces Board Change

MONTREAL, CANADA: ...

Flamel Technologies Announces Price Change for Bloxiverz

LYON, FRANCE: ...

Canadian Cannabis Corp. Appoints Richard Wachsberg as Independent Director

TORONTO, ONTARIO: ...

Willie L. Brown, Jr. Joins the Board of Directors of Global Blood Therapeutics

SOUTH SAN FRANCISCO, CA: California Statesman Brings More Than 50 Years of Broad-Ranging Experience to Support Development of Groundbreaking Treatment for Sickle Cell Disease ...

AntriaBio Announces Completion of PK/PD Studies of AB101 in Two Species

LOUISVILLE, CO: AB101 Positioned to Be the First Once-Weekly Basal Insulin for Diabetes Patients ...

SciClone Provides 2014 Financial Update and 2015 Revenue Guidance

FOSTER CITY, CA: ...

Insys Therapeutics to Present at 33rd Annual J.P. Morgan Healthcare Conference

PHOENIX, AZ: ...

Cellceutix Releases Confidence Interval Statistics Showing Clinical Success Rates for Brilacidin in Treatment of ABSSSI

BEVERLY, MA: ...